Clifford Group LLC Sells 408 Shares of CVS Health Co. (NYSE:CVS)

Clifford Group LLC lessened its stake in shares of CVS Health Co. (NYSE:CVSFree Report) by 5.1% in the 2nd quarter, according to its most recent disclosure with the SEC. The firm owned 7,527 shares of the pharmacy operator’s stock after selling 408 shares during the period. Clifford Group LLC’s holdings in CVS Health were worth $445,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also bought and sold shares of CVS. Ables Iannone Moore & Associates Inc. bought a new stake in CVS Health during the 4th quarter worth approximately $32,000. First Community Trust NA raised its position in shares of CVS Health by 116.2% during the 2nd quarter. First Community Trust NA now owns 562 shares of the pharmacy operator’s stock valued at $33,000 after purchasing an additional 302 shares during the period. Creekmur Asset Management LLC purchased a new position in shares of CVS Health during the 4th quarter valued at $34,000. Steph & Co. increased its stake in CVS Health by 192.0% in the 1st quarter. Steph & Co. now owns 438 shares of the pharmacy operator’s stock worth $35,000 after buying an additional 288 shares in the last quarter. Finally, ORG Partners LLC raised its holdings in CVS Health by 11,840.0% during the second quarter. ORG Partners LLC now owns 597 shares of the pharmacy operator’s stock valued at $35,000 after acquiring an additional 592 shares during the period. Hedge funds and other institutional investors own 80.66% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research firms recently issued reports on CVS. Evercore ISI cut their target price on CVS Health from $65.00 to $62.00 and set an “outperform” rating for the company in a research report on Thursday, August 8th. Royal Bank of Canada reissued an “outperform” rating and issued a $68.00 target price on shares of CVS Health in a report on Wednesday, September 4th. Baird R W upgraded shares of CVS Health to a “hold” rating in a report on Thursday, May 30th. JPMorgan Chase & Co. dropped their price objective on shares of CVS Health from $101.00 to $86.00 and set an “overweight” rating for the company in a report on Thursday, May 30th. Finally, Wells Fargo & Company lifted their target price on CVS Health from $60.00 to $61.00 and gave the stock an “equal weight” rating in a report on Monday, August 12th. Eleven equities research analysts have rated the stock with a hold rating and eleven have given a buy rating to the company. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $72.10.

Get Our Latest Stock Analysis on CVS Health

CVS Health Trading Down 0.0 %

CVS stock opened at $58.40 on Friday. The company has a quick ratio of 0.66, a current ratio of 0.86 and a debt-to-equity ratio of 0.83. CVS Health Co. has a twelve month low of $52.77 and a twelve month high of $83.25. The stock has a market capitalization of $73.31 billion, a price-to-earnings ratio of 10.26, a price-to-earnings-growth ratio of 0.79 and a beta of 0.53. The firm’s fifty day simple moving average is $58.34 and its two-hundred day simple moving average is $62.71.

CVS Health (NYSE:CVSGet Free Report) last posted its quarterly earnings data on Wednesday, August 7th. The pharmacy operator reported $1.83 earnings per share for the quarter, beating analysts’ consensus estimates of $1.73 by $0.10. CVS Health had a net margin of 1.98% and a return on equity of 12.72%. The business had revenue of $91.23 billion for the quarter, compared to analysts’ expectations of $91.41 billion. During the same quarter in the previous year, the business posted $2.21 earnings per share. The business’s revenue was up 2.6% compared to the same quarter last year. As a group, analysts anticipate that CVS Health Co. will post 6.51 earnings per share for the current year.

CVS Health Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Thursday, August 1st. Stockholders of record on Monday, July 22nd were paid a dividend of $0.665 per share. This represents a $2.66 dividend on an annualized basis and a dividend yield of 4.55%. The ex-dividend date was Monday, July 22nd. CVS Health’s dividend payout ratio is currently 46.75%.

CVS Health Profile

(Free Report)

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.

Featured Articles

Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Co. (NYSE:CVSFree Report).

Institutional Ownership by Quarter for CVS Health (NYSE:CVS)

Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.